Araris Biotech
ID: 7354095Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
3
Funding Rounds
$33.5m
Money raised
Recent Funding Rounds
Overview
Araris Biotech is a fast/precise production of antibody-drug conjugates founded in 2019 by Philipp Spycher.
- Business model: B2B
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Is****** At************* |
|
- | - |
| Ph***** Sp***** |
|
- |
Funding
Funding series
Funding Series Analysis
The company Araris Biotech has raised a total of $19.5m in funding over 3 rounds.
Key Insights:
- Araris Biotech October 2020 Seed Funding Round: $17m
- Araris Biotech Seed round, August 2019: $2.5m
- Araris Biotech Seed round October 2020: $14m
Industries
Araris Biotech is active in the following industries: